- Report
- October 2024
- 450 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- July 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 148 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Book
- May 2024
- 368 Pages
- Book
- November 2022
- 176 Pages
- Book
- September 2022
- 352 Pages
- Book
- April 2021
- 432 Pages
- Book
- April 2020
- 336 Pages
- Book
- April 2019
- 176 Pages
- Book
- June 2015
- 392 Pages
- Book
- January 2014
- 384 Pages
- Book
- March 2008
- 352 Pages

Autoimmunity is a medical condition in which the body's immune system mistakenly attacks healthy cells, tissues, and organs. It is a subset of Allergy and Immunology, which is the study of the body's immune system and its response to foreign substances. Autoimmune diseases can affect any part of the body, including the skin, joints, muscles, and organs. Symptoms vary depending on the type of autoimmune disease, but can include fatigue, joint pain, skin rashes, and fever. Treatment for autoimmune diseases typically involves medications to suppress the immune system and reduce inflammation.
The Autoimmunity market is a rapidly growing sector of the Allergy and Immunology industry. It is driven by the increasing prevalence of autoimmune diseases, as well as advances in diagnosis and treatment. Companies in the Autoimmunity market include AbbVie, AstraZeneca, Biogen, Celgene, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Regeneron, and Sanofi. Show Less Read more